TCR2 Therapeutics | 4:持股变动声明-股东 TANG KEVIN C
02/15 06:29
TCR2 Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(0%),TANG CAPITAL MANAGEMENT, LLC(0%)等
02/15 05:03
TCR2 Therapeutics | 4:持股变动声明-股东 UBS Oncology Impact Fund L.P.
2023/06/06 04:37
TCR2 Therapeutics | 4:持股变动声明-股东 MPM SunStates Fund, L.P.
2023/06/06 04:36
TCR2 Therapeutics | 4:持股变动声明-股东 MPM BioVentures 2014, L.P.
2023/06/06 04:36
TCR2 Therapeutics | 4:持股变动声明-董事 GADICKE ANSBERT
2023/06/06 04:35
TCR2 Therapeutics | 4:持股变动声明-董事 Allen Andrew R
2023/06/02 04:33
TCR2 Therapeutics | 4:持股变动声明-董事 Tomasello Shawn
2023/06/02 04:32
TCR2 Therapeutics | 4:持股变动声明-首席财务官 Sullivan Eric
2023/06/02 04:31
TCR2 Therapeutics | 4:持股变动声明-高管 Cardama Alfonso Quintas
2023/06/02 04:29
TCR2 Therapeutics | 4:持股变动声明-首席运营官 Olagunju Peter
2023/06/02 04:27
TCR2 Therapeutics | 4:持股变动声明-董事 Webster Stephen W
2023/06/02 04:25
TCR2 Therapeutics | 4:持股变动声明-高管 Harrison Rosemary
2023/06/02 04:23
TCR2 Therapeutics | 4:持股变动声明-高管 Menzel Garry E
2023/06/02 04:22
TCR2 Therapeutics | 4:持股变动声明-首席人事官 Justice Angela
2023/06/02 04:21
TCR2 Therapeutics | 4:持股变动声明-董事 Hoos Axel
2023/06/02 04:20
TCR2 Therapeutics | 4:持股变动声明-董事 Hegde Priti
2023/06/02 04:18
TCR2 Therapeutics | 4:持股变动声明-董事 Gibson Neil W
2023/06/02 04:15
TCR2 Therapeutics | 4:持股变动声明-股东 TANG KEVIN C
2023/05/31 08:02
TCR2 Therapeutics | 4:持股变动声明-股东 MPM ASSET MANAGEMENT LLC
2023/05/25 04:39
暂无数据
暂无数据